Bupropion Hydrochloride
- Product NDC
- 68788-7221
- 11-digit product format
- 687887221
- Labeler code
- 68788
- Product ID
- 68788-7221_5780b8e1-58c3-4486-b0d6-64684e673ec5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA077285
- Marketing category
- ANDA
- Marketing start
- 2018-07-26
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7221-1 | 68788722101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7221-1) | 2018-07-26 | 0000-00-00 | No | No | Current |
| 68788-7221-3 | 68788722103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7221-3) | 2018-07-26 | 0000-00-00 | No | No | Current |
| 68788-7221-6 | 68788722106 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7221-6) | 2018-07-26 | 0000-00-00 | No | No | Current |
| 68788-7221-8 | 68788722108 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7221-8) | 2018-07-26 | 0000-00-00 | No | No | Current |
| 68788-7221-9 | 68788722109 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7221-9) | 2018-07-26 | 0000-00-00 | No | No | Current |